Royal Philips and BioIntelliSense are set to receive about $2.8m funding from the US Department of Defense (DoD) to validate BioIntelliSense’s FDA-cleared BioSticker device...
Aerus Medical formally announced the start of a double-blind two-year clinical study to evaluate the impact the Aerus Medical Guardian with ActivePure Technology can have on reducing...
Smith+Nephew is touting what it is describing as outstanding clinical results for its total hip arthroplasty (THA) portfolio.
The results — in both the National...
TRIDENT will test the potential survival benefit of initiating Optune concurrent with radiation therapy in patients with newly diagnosed glioblastoma
Preclinical studies demonstrate that Tumor...
Results of the clinical study showed Imbed Biosciences' Microlyte Matrix, a bioresorbable polymeric matrix, significantly improved wound healing.
Imbed Biosciences, a privately held biotech company,...
EVAQ is a multi-centre, single-arm trial, designed to evaluate the MIVI Q Revascularisation System for neuro intervention in acute ischemic stroke patients
MIVI Neuroscience enrols...
A new public-private partnership may bring the clinical trial of a dialysis device to the Manchester VA.
The device, the CVS Kidney Care’s HemoCare Hemodialysis...
A two-year study conducted in the UK recorded a 23% improvement in wound healing after treatment with fluorescence point-of-care imaging
A growing body of evidence...
